ProGem1: Phase I first-in-human study of the novel nucleotide NUC-1031 in adult patients with advanced solid tumors. A first-in-human phase I study of CZ48, a lactone ring protected oral camptothecin, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback